BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$77.75
0.56 (0.73%)
▲
5d:
+10.69%
30d:
+18.74%
90d:
+6.29%
HOLD
MODERATE Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 04, 2026
27d
Smart Money Accumulation
None View Scanner →
Strength: 6.5/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called BBIO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BBIO is 7.4% above its trading range ($72.39). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BBIO is 7.4% above its trading range ($72.39). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $77.75, which is considered extended relative to its 30-day fair value range of $65.48 to $72.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 147.4) compared to its historical average (211.5). Remarkably, the market is currently pricing in an annual earnings decline of 11.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is approaching resistance at $79.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+31.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is approaching resistance at $79.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $102.28 (+31.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$65.48 -
$72.39
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
BBIO is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.5% below Wall St target ($102.28)
Trading Range Analysis
30-Day Trading Range
$65.48 -
$72.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$66.30
Resistance Level
$79.25
Current Trend
Strong Uptrend
Technical data as of
Jul 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
147.45
Wall Street Target
$102.28
(+31.5%)
Revenue Growth (YoY)
66.8%
Profit Margin
-124.4%
Valuation Discount vs History
-11.3% cheaper
PE vs Historical
147.5 vs 211.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.3%
(market-implied from PE analysis)
1-Year Target
$69.97
(-10%)
2-Year Target
$62.98
(-19%)
3-Year Target
$56.68
(-27%)
3-Yr Target (if PE normalizes)
(PE: 147→212)
$81.30
(+5%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 147.4 to 211.5
Stabilization Target:
$111.52
(+43.4%)
PE Expansion Potential:
+43.4%
Share & Embed Analysis
Last updated: July 07, 2026 5:56 AM ET
Data refreshes hourly during market hours. Next update: 6:56 AM
Data refreshes hourly during market hours. Next update: 6:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 68 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 62 BUY |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
